{"nct_id":"NCT01515189","title":"Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab","status":"COMPLETED","status_verified_date":"2019-07","start_date":"2012-02-17","start_date_type":"ACTUAL","primary_completion_date":"2016-02-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-08-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}